| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.65 | 0.008 | 0.65 | Immunomodulator | 0.57 0.014 CID_162951 | ||
| 0.64 | 0.004 | 0.64 | Interleukin 4 antagonist | 0.247 0.014 CID_162951 | ||
| 0.634 | 0.014 | 0.634 | Toll-Like receptor agonist | 0.346 0.084 CID_162951 | ||
| 0.611 | 0.016 | 0.611 | Toll-Like receptor 7 agonist | 0.274 0.128 CID_162951 | ||
| 0.565 | 0.008 | 0.565 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.564 | 0.008 | 0.564 | Dyrk kinase inhibitor | |||
| 0.53 | 0.019 | 0.53 | GABA C receptor rho-3 antagonist | |||
| 0.452 | 0.014 | 0.452 | Peroxidase inhibitor | |||
| 0.438 | 0.003 | 0.438 | Electrolyte absorption antagonist | 0.195 0.009 CID_162951 | ||
| 0.449 | 0.014 | 0.509 | RNA-directed DNA polymerase inhibitor | 0.509 0.01 CID_162951 | CID_162951 | |
| 0.431 | 0.002 | 0.431 | Folate antagonist | 0.324 0.003 CID_162951 | ||
| 0.439 | 0.011 | 0.77 | Diuretic | 0.77 0.003 CID_162951 | CID_162951 | |
| 0.43 | 0.006 | 0.43 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.102 0.099 CID_162951 | ||
| 0.419 | 0.003 | 0.419 | Phenylalanine 4-hydroxylase inhibitor | 0.141 0.013 CID_162951 | ||
| 0.432 | 0.018 | 0.432 | DNA synthesis inhibitor | 0.296 0.045 CID_162951 | ||
| 0.439 | 0.055 | 0.439 | Histamine release inhibitor | 0.33 0.109 CID_162951 | ||
| 0.396 | 0.018 | 0.396 | Death-associated protein kinase 3 inhibitor | |||
| 0.36 | 0.008 | 0.36 | Heat shock protein 90 alpha antagonist | |||
| 0.356 | 0.005 | 0.356 | Heat shock protein 90 antagonist | |||
| 0.362 | 0.013 | 0.362 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.137 0.087 CID_162951 | ||
| 0.368 | 0.024 | 0.368 | Clk dual-specificity kinase inhibitor | |||
| 0.376 | 0.037 | 0.376 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.342 | 0.018 | 0.342 | DNA methylase inhibitor | |||
| 0.326 | 0.01 | 0.326 | Protein kinase (CK1) delta inhibitor | 0.099 0.093 CID_162951 | ||
| 0.323 | 0.01 | 0.323 | Cyclin-dependent kinase 1 inhibitor | 0.116 0.057 CID_162951 | ||
| 0.327 | 0.016 | 0.327 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.325 | 0.014 | 0.325 | Protein kinase (CK1) inhibitor | |||
| 0.328 | 0.021 | 0.328 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.314 | 0.019 | 0.314 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.296 | 0.005 | 0.296 | Adenosine A2a receptor antagonist | 0.128 0.018 CID_162951 | ||
| 0.341 | 0.057 | 0.341 | Aldehyde oxidase inhibitor | |||
| 0.3 | 0.018 | 0.3 | Protein kinase (CK1) gamma inhibitor | 0.115 0.095 CID_162951 | ||
| 0.31 | 0.029 | 0.31 | CDC-like kinase 2 inhibitor | |||
| 0.286 | 0.006 | 0.286 | Adenosine A2 receptor antagonist | 0.117 0.023 CID_162951 | ||
| 0.287 | 0.007 | 0.287 | Adenosine A1 receptor antagonist | 0.248 0.008 CID_162951 | ||
| 0.281 | 0.004 | 0.281 | Interferon agonist | 0.266 0.004 CID_162951 | ||
| 0.288 | 0.011 | 0.288 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.311 | 0.036 | 0.311 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.339 | 0.068 | 0.385 | Immunostimulant | 0.385 0.054 CID_162951 | CID_162951 | |
| 0.288 | 0.019 | 0.288 | Protein kinase (CK1) gamma 3 inhibitor | 0.154 0.085 CID_162951 | ||
| 0.301 | 0.035 | 0.301 | MAP kinase kinase 2 inhibitor | |||
| 0.403 | 0.138 | 0.456 | Antiinflammatory | 0.456 0.107 CID_162951 | CID_162951 | |
| 0.277 | 0.018 | 0.277 | Nitric-oxide synthase stimulant | |||
| 0.29 | 0.039 | 0.29 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.273 | 0.028 | 0.273 | LIM domain kinase 1 inhibitor | |||
| 0.267 | 0.029 | 0.267 | I kappa B kinase epsilon inhibitor | |||
| 0.257 | 0.019 | 0.257 | Protein kinase (CK1) gamma 2 inhibitor | 0.095 0.09 CID_162951 | ||
| 0.267 | 0.03 | 0.267 | Neurotrophic factor enhancer | |||
| 0.242 | 0.006 | 0.242 | Phosphatidylinositol 3-kinase delta inhibitor | |||
| 0.242 | 0.007 | 0.242 | Adenosine A3 receptor antagonist | 0.093 0.031 CID_162951 | ||
| 0.349 | 0.116 | 0.349 | 5 Hydroxytryptamine release inhibitor | |||
| 0.256 | 0.026 | 0.256 | Cyclin-dependent kinase inhibitor | |||
| 0.246 | 0.016 | 0.246 | Toll-Like receptor antagonist | |||
| 0.233 | 0.004 | 0.233 | Glutamate release inhibitor | 0.085 0.074 CID_162951 | ||
| 0.268 | 0.039 | 0.268 | DNA methyltransferase I inhibitor | |||
| 0.273 | 0.046 | 0.273 | EphB2 antagonist | |||
| 0.25 | 0.024 | 0.25 | Cytokine production inhibitor | 0.183 0.042 CID_162951 | ||
| 0.266 | 0.041 | 0.266 | CDC-like kinase 4 inhibitor | |||
| 0.244 | 0.019 | 0.244 | CDC-like kinase 1 inhibitor | |||
| 0.304 | 0.084 | 0.304 | Vasodilator, coronary | |||
| 0.234 | 0.015 | 0.234 | CDK/cyclin complex inhibitor | 0.083 0.065 CID_162951 | ||
| 0.234 | 0.018 | 0.234 | Protein kinase (CK2) alpha inhibitor | |||
| 0.247 | 0.035 | 0.247 | Protein kinase C nu inhibitor | |||
| 0.219 | 0.01 | 0.219 | Alcohol dehydrogenase inhibitor | |||
| 0.216 | 0.009 | 0.216 | CDK1/cyclin B inhibitor | 0.067 0.041 CID_162951 | ||
| 0.222 | 0.015 | 0.222 | Protein kinase (CK2) inhibitor | |||
| 0.237 | 0.03 | 0.237 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.21 | 0.004 | 0.21 | Purinergic P2X2 antagonist | 0.185 0.006 CID_162951 | ||
| 0.216 | 0.014 | 0.216 | CF transmembrane conductance regulator agonist | |||
| 0.285 | 0.085 | 0.285 | Streptokinase A inhibitor | |||
| 0.201 | 0.007 | 0.201 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.068 0.027 CID_162951 | ||
| 0.22 | 0.028 | 0.22 | Toll-Like receptor 9 antagonist | |||
| 0.222 | 0.03 | 0.222 | Interleukin 6 antagonist | |||
| 0.245 | 0.058 | 0.245 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.19 | 0.004 | 0.19 | Heat shock protein 90 beta antagonist | |||
| 0.202 | 0.016 | 0.202 | Fibroblast growth factor 1 antagonist | 0.187 0.019 CID_162951 | ||
| 0.191 | 0.011 | 0.191 | NADH dehydrogenase inhibitor | 0.113 0.032 CID_162951 | ||
| 0.243 | 0.064 | 0.243 | Interleukin antagonist | |||
| 0.182 | 0.005 | 0.182 | Cyclin B inhibitor | 0.073 0.019 CID_162951 | ||
| 0.179 | 0.002 | 0.29 | Dihydrofolate reductase inhibitor | 0.29 0.002 CID_162951 | CID_162951 | |
| 0.329 | 0.152 | 0.329 | MAP kinase 1 inhibitor | |||
| 0.183 | 0.006 | 0.183 | Interleukin 5 antagonist | 0.078 0.077 CID_162951 | ||
| 0.18 | 0.004 | 0.181 | Phosphoglycerate kinase inhibitor | 0.181 0.004 CID_162951 | CID_162951 | |
| 0.182 | 0.007 | 0.182 | Myeloperoxidase inhibitor | |||
| 0.218 | 0.046 | 0.218 | Src kinase inhibitor | |||
| 0.196 | 0.025 | 0.196 | Cyclin-dependent kinase 2 inhibitor | |||
| 0.173 | 0.004 | 0.173 | Interferon inducer | 0.165 0.004 CID_162951 | ||
| 0.208 | 0.039 | 0.208 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.188 | 0.019 | 0.188 | MAP kinase kinase 4 inhibitor | |||
| 0.202 | 0.035 | 0.202 | c-Src kinase inhibitor | |||
| 0.196 | 0.029 | 0.196 | DNA polymerase I inhibitor | 0.098 0.088 CID_162951 | ||
| 0.176 | 0.009 | 0.176 | Cyclin B3 inhibitor | |||
| 0.176 | 0.01 | 0.176 | Phosphatidylinositol kinase inhibitor | |||
| 0.201 | 0.036 | 0.201 | Ribosomal protein S6 kinase inhibitor | |||
| 0.298 | 0.137 | 0.422 | Antibacterial | 0.422 0.067 CID_162951 | CID_162951 | |
| 0.27 | 0.109 | 0.541 | Angiogenesis inhibitor | 0.541 0.023 CID_162951 | CID_162951 | |
| 0.176 | 0.015 | 0.176 | DNA repair enzyme inhibitor | 0.113 0.087 CID_162951 | ||
| 0.165 | 0.005 | 0.165 | Cyclin B1 inhibitor | 0.078 0.024 CID_162951 | ||
| 0.164 | 0.005 | 0.164 | Cyclin B2 inhibitor | 0.073 0.019 CID_162951 | ||
| 0.165 | 0.007 | 0.165 | mTOR complex 2 inhibitor | |||
| 0.186 | 0.031 | 0.186 | MAP kinase 3 inhibitor | |||
| 0.214 | 0.064 | 0.214 | Tyrosine kinase inhibitor | |||
| 0.17 | 0.02 | 0.17 | CDK2/cyclin A inhibitor | |||
| 0.265 | 0.117 | 0.265 | Vasodilator, peripheral | |||
| 0.191 | 0.042 | 0.191 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.179 | 0.03 | 0.179 | Adenylate cyclase inhibitor | |||
| 0.15 | 0.003 | 0.15 | Dihydropteroate synthase inhibitor | 0.061 0.011 CID_162951 | ||
| 0.161 | 0.016 | 0.161 | Aminoacyl-tRNA synthetase inhibitor | 0.108 0.038 CID_162951 | ||
| 0.231 | 0.088 | 0.231 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.192 | 0.05 | 0.192 | Polo-like kinase-3 inhibitor | |||
| 0.154 | 0.013 | 0.154 | Histamine N-methyltransferase inhibitor | |||
| 0.156 | 0.016 | 0.156 | AXL receptor tyrosine kinase inhibitor | |||
| 0.177 | 0.039 | 0.177 | Topoisomerase II inhibitor | |||
| 0.154 | 0.016 | 0.154 | CDK2/cyclin E2 inhibitor | |||
| 0.297 | 0.16 | 0.297 | Calcium channel L-type activator | |||
| 0.137 | 0.003 | 0.137 | MAP kinase kinase 7 inhibitor | |||
| 0.256 | 0.123 | 0.256 | Transcription factor NF kappa B inhibitor | |||
| 0.177 | 0.045 | 0.177 | GABA C receptor rho-2 antagonist | |||
| 0.142 | 0.014 | 0.142 | CDK2/cyclin E inhibitor | 0.064 0.039 CID_162951 | ||
| 0.164 | 0.037 | 0.164 | Aurora-C kinase inhibitor | |||
| 0.134 | 0.007 | 0.134 | Adenosine A2b receptor antagonist | 0.063 0.022 CID_162951 | ||
| 0.138 | 0.012 | 0.138 | Cyclin E inhibitor | |||
| 0.156 | 0.032 | 0.156 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.138 | 0.015 | 0.138 | Cyclin A2 inhibitor | |||
| 0.189 | 0.069 | 0.189 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.19 | 0.07 | 0.19 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.154 | 0.036 | 0.154 | MAP kinase 9 inhibitor | |||
| 0.143 | 0.029 | 0.143 | Adenylate kinase inhibitor | 0.1 0.067 CID_162951 | ||
| 0.124 | 0.013 | 0.124 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.132 | 0.022 | 0.132 | Phosphofructokinase-1 inhibitor | 0.059 0.058 CID_162951 | ||
| 0.146 | 0.036 | 0.146 | Xanthine oxidase inhibitor | |||
| 0.116 | 0.007 | 0.116 | Phosphodiesterase VIII inhibitor | 0.093 0.019 CID_162951 | ||
| 0.112 | 0.005 | 0.112 | Guanylate cyclase stimulant | 0.046 0.026 CID_162951 | ||
| 0.12 | 0.014 | 0.12 | Cyclin E1 inhibitor | |||
| 0.135 | 0.028 | 0.135 | Phosphodiesterase 7B inhibitor | |||
| 0.123 | 0.017 | 0.123 | Cyclin A inhibitor | |||
| 0.157 | 0.051 | 0.157 | Adenylate cyclase stimulant | 0.136 0.09 CID_162951 | ||
| 0.14 | 0.035 | 0.14 | Check point kinase 2 inhibitor | |||
| 0.112 | 0.008 | 0.112 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.088 0.024 CID_162951 | ||
| 0.119 | 0.015 | 0.119 | I kappa B kinase 1 inhibitor | |||
| 0.127 | 0.023 | 0.127 | I kappa B kinase inhibitor | |||
| 0.107 | 0.004 | 0.107 | AICAR transformylase inhibitor | 0.091 0.005 CID_162951 | ||
| 0.161 | 0.059 | 0.161 | Lck kinase inhibitor | |||
| 0.148 | 0.047 | 0.148 | Aurora-B kinase inhibitor | |||
| 0.116 | 0.016 | 0.116 | Argininosuccinate synthase inhibitor | |||
| 0.123 | 0.025 | 0.123 | mTOR complex 1 inhibitor | |||
| 0.121 | 0.024 | 0.121 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.118 | 0.023 | 0.118 | Glutamate dehydrogenase inhibitor | 0.068 0.059 CID_162951 | ||
| 0.156 | 0.062 | 0.156 | Activin receptor-like kinase 2 inhibitor | |||
| 0.129 | 0.035 | 0.129 | Creatine kinase inhibitor | |||
| 0.156 | 0.063 | 0.156 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.147 | 0.054 | 0.147 | Heat shock protein 70 antagonist | |||
| 0.151 | 0.059 | 0.151 | MAP3K9 inhibitor | |||
| 0.11 | 0.02 | 0.11 | D-Ala-D-Ala ligase inhibitor | |||
| 0.109 | 0.019 | 0.109 | CDC7 inhibitor | |||
| 0.094 | 0.005 | 0.094 | Thymidylate synthase inhibitor | 0.047 0.032 CID_162951 | ||
| 0.203 | 0.114 | 0.235 | Superoxide dismutase inhibitor | 0.235 0.085 CID_162951 | CID_162951 | |
| 0.101 | 0.015 | 0.101 | Xanthine dehydrogenase inhibitor | |||
| 0.104 | 0.019 | 0.104 | Transforming growth factor beta 3 antagonist | |||
| 0.13 | 0.045 | 0.13 | Ephrin antagonist | |||
| 0.099 | 0.015 | 0.099 | Phosphatidylinositol 3-kinase gamma inhibitor | |||
| 0.124 | 0.04 | 0.124 | DOPA decarboxylase inhibitor | |||
| 0.108 | 0.026 | 0.108 | CDK1/cyclin B1 inhibitor | |||
| 0.113 | 0.031 | 0.113 | Phosphodiesterase 4D inhibitor | |||
| 0.128 | 0.047 | 0.128 | Transcription factor STAT6 inhibitor | |||
| 0.089 | 0.009 | 0.089 | Epithelial sodium channel blocker | |||
| 0.097 | 0.017 | 0.097 | Purinergic P2X1 antagonist | |||
| 0.133 | 0.054 | 0.133 | Beta amyloid protein antagonist | |||
| 0.185 | 0.106 | 0.185 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.095 | 0.018 | 0.095 | Phosphatidylinositol 3-kinase alpha inhibitor | |||
| 0.187 | 0.11 | 0.187 | Aryl hydrocarbon receptor agonist | |||
| 0.176 | 0.099 | 0.176 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.213 | 0.137 | 0.213 | 12-Lipoxygenase inhibitor | |||
| 0.109 | 0.035 | 0.109 | Topoisomerase II alpha inhibitor | |||
| 0.111 | 0.037 | 0.111 | Toll-Like receptor 3 antagonist | |||
| 0.114 | 0.042 | 0.114 | Nitric-oxide synthase inhibitor | 0.112 0.044 CID_162951 | ||
| 0.171 | 0.099 | 0.171 | Focal adhesion kinase 2 inhibitor | |||
| 0.08 | 0.009 | 0.08 | Adenosine deaminase inhibitor | 0.068 0.014 CID_162951 | ||
| 0.115 | 0.045 | 0.115 | GABA C receptor rho-1 antagonist | |||
| 0.088 | 0.018 | 0.088 | Antimetabolite | |||
| 0.161 | 0.092 | 0.161 | TRKC antagonist | |||
| 0.191 | 0.124 | 0.191 | DNA damaging | |||
| 0.122 | 0.056 | 0.122 | Cystathionine beta-synthase inhibitor | |||
| 0.088 | 0.023 | 0.088 | Biliverdin reductase inhibitor | |||
| 0.124 | 0.059 | 0.124 | Glycogen synthase kinase-3 inhibitor | |||
| 0.166 | 0.102 | 0.166 | Pyruvate kinase inhibitor | |||
| 0.087 | 0.025 | 0.087 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.117 | 0.056 | 0.117 | GABA C receptor antagonist | |||
| 0.108 | 0.047 | 0.108 | DNA directed RNA polymerase inhibitor | |||
| 0.079 | 0.019 | 0.079 | Cyclin D1 inhibitor | |||
| 0.207 | 0.149 | 0.207 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.104 | 0.046 | 0.127 | Protein kinase C zeta inhibitor | 0.127 0.029 CID_162951 | CID_162951 | |
| 0.066 | 0.009 | 0.066 | Cytokine production stimulant | |||
| 0.068 | 0.012 | 0.068 | CDK5/p25 inhibitor | |||
| 0.092 | 0.038 | 0.092 | Fibroblast growth factor 3 antagonist | |||
| 0.11 | 0.057 | 0.11 | GABA C receptor agonist | |||
| 0.129 | 0.077 | 0.129 | Cyclin-dependent kinase 7 inhibitor | |||
| 0.111 | 0.061 | 0.111 | Protein kinase C gamma inhibitor | |||
| 0.12 | 0.07 | 0.12 | MAP kinase 12 inhibitor | |||
| 0.091 | 0.043 | 0.091 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.07 | 0.024 | 0.07 | Urokinase inhibitor | |||
| 0.071 | 0.026 | 0.071 | CDK4/cyclin D inhibitor | |||
| 0.15 | 0.106 | 0.151 | Phospholipase C inhibitor | 0.151 0.104 CID_162951 | CID_162951 | |
| 0.078 | 0.035 | 0.084 | Fibroblast growth factor 2 antagonist | 0.084 0.031 CID_162951 | CID_162951 | |
| 0.094 | 0.052 | 0.094 | Pim-3 kinase inhibitor | |||
| 0.127 | 0.085 | 0.127 | Growth factor antagonist | |||
| 0.065 | 0.025 | 0.065 | mTOR inhibitor | |||
| 0.092 | 0.051 | 0.092 | Protein kinase A inhibitor | |||
| 0.045 | 0.004 | 0.045 | Toll-Like receptor 8 agonist | |||
| 0.085 | 0.044 | 0.085 | Porphobilinogen synthase inhibitor | |||
| 0.103 | 0.063 | 0.103 | Carbonic anhydrase XV inhibitor | |||
| 0.048 | 0.009 | 0.048 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.058 | 0.02 | 0.058 | Histamine H4 receptor antagonist | |||
| 0.131 | 0.094 | 0.417 | Hemostatic | 0.417 0.007 CID_162951 | CID_162951 | |
| 0.066 | 0.029 | 0.066 | Bruton tyrosine kinase inhibitor | |||
| 0.06 | 0.024 | 0.06 | Phosphatidylinositol 3-kinase beta inhibitor | |||
| 0.25 | 0.214 | 0.25 | Apoptosis agonist | |||
| 0.067 | 0.032 | 0.067 | Cyclin H inhibitor | |||
| 0.097 | 0.064 | 0.097 | UDP-glucose 4-epimerase inhibitor | |||
| 0.066 | 0.034 | 0.066 | CDK4/cyclin D1 inhibitor | |||
| 0.092 | 0.062 | 0.092 | Potassium channel (Ca-activated) activator | |||
| 0.076 | 0.047 | 0.076 | Protein kinase B beta inhibitor | |||
| 0.08 | 0.052 | 0.08 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | |||
| 0.131 | 0.103 | 0.131 | Hexokinase inhibitor | |||
| 0.046 | 0.019 | 0.046 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.102 | 0.075 | 0.102 | Glycogen synthase kinase-3 beta inhibitor | |||
| 0.048 | 0.021 | 0.051 | Thymidine kinase inhibitor | 0.051 0.018 CID_162951 | CID_162951 | |
| 0.092 | 0.066 | 0.092 | Pim-1 kinase inhibitor | |||
| 0.038 | 0.013 | 0.038 | Estrogen-related receptor beta antagonist | |||
| 0.098 | 0.073 | 0.098 | Ferrochelatase inhibitor | |||
| 0.11 | 0.085 | 0.11 | MAP kinase kinase inhibitor | |||
| 0.102 | 0.077 | 0.102 | MAP kinase 13 inhibitor | |||
| 0.139 | 0.115 | 0.139 | Tumour necrosis factor antagonist | |||
| 0.027 | 0.004 | 0.027 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.021 0.006 CID_162951 | ||
| 0.058 | 0.035 | 0.058 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.093 | 0.07 | 0.128 | Aminopeptidase B inhibitor | 0.128 0.048 CID_162951 | CID_162951 | |
| 0.059 | 0.036 | 0.059 | Alcohol oxidase inhibitor | |||
| 0.037 | 0.014 | 0.037 | Cyclin E2 inhibitor | |||
| 0.027 | 0.006 | 0.027 | Adenosine A2a receptor agonist | |||
| 0.035 | 0.015 | 0.036 | Purinergic P2X agonist | 0.036 0.014 CID_162951 | CID_162951 | |
| 0.027 | 0.008 | 0.027 | Guanylate cyclase 1 stimulant | |||
| 0.025 | 0.006 | 0.025 | Adenosine A2 receptor agonist | |||
| 0.055 | 0.035 | 0.055 | Ornithine carbamoyltransferase inhibitor | |||
| 0.143 | 0.124 | 0.143 | Death-associated protein kinase 2 inhibitor | |||
| 0.038 | 0.02 | 0.038 | Fumarate hydratase inhibitor | |||
| 0.11 | 0.092 | 0.11 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.071 | 0.053 | 0.212 | Cathepsin G inhibitor | 0.212 0.015 CID_162951 | CID_162951 | |
| 0.074 | 0.056 | 0.074 | GABA B receptor agonist | |||
| 0.168 | 0.151 | 0.168 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.168 | 0.151 | 0.168 | Interleukin agonist | |||
| 0.105 | 0.089 | 0.105 | Aldehyde dehydrogenase inhibitor | |||
| 0.034 | 0.02 | 0.034 | Protein kinase (CK2) beta inhibitor | |||
| 0.075 | 0.062 | 0.075 | Platelet growth factor antagonist | |||
| 0.03 | 0.018 | 0.03 | Purinergic P2Y15 antagonist | |||
| 0.033 | 0.021 | 0.033 | ATR kinase inhibitor | |||
| 0.018 | 0.006 | 0.018 | Adenosine A2b receptor agonist | |||
| 0.04 | 0.028 | 0.04 | Dopamine D5 agonist | |||
| 0.019 | 0.007 | 0.019 | S-adenosyl-L-homocysteine hydrolase inhibitor | |||
| 0.015 | 0.005 | 0.015 | Purine nucleoside phosphorylase inhibitor | |||
| 0.1 | 0.09 | 0.1 | TRKA antagonist | |||
| 0.031 | 0.021 | 0.031 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.018 | 0.01 | 0.018 | Adenosine A3 receptor agonist | |||
| 0.024 | 0.016 | 0.024 | Adenosine A1 receptor agonist | |||
| 0.09 | 0.083 | 0.09 | Estrogen receptor beta antagonist | |||
| 0.21 | 0.203 | 0.21 | 15-Lipoxygenase inhibitor | |||
| 0.082 | 0.075 | 0.082 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.016 | 0.009 | 0.016 | Purinergic P2Y1 agonist | 0.016 0.01 CID_162951 | ||
| 0.081 | 0.074 | 0.081 | Phosphodiesterase I inhibitor | |||
| 0.053 | 0.046 | 0.053 | EphB4 antagonist | |||
| 0.017 | 0.011 | 0.017 | Tryptophan hydroxylase 1 inhibitor | |||
| 0.035 | 0.028 | 0.035 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.032 | 0.027 | 0.032 | RNA-directed RNA polymerase inhibitor | |||
| 0.1 | 0.096 | 0.1 | Interleukin 8 antagonist | |||
| 0.008 | 0.004 | 0.008 | Phosphoribosylglycinamide formyltransferase inhibitor | |||
| 0.018 | 0.015 | 0.018 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.082 | 0.078 | 0.082 | Protein kinase C mu inhibitor | |||
| 0.089 | 0.087 | 0.089 | Tyrosine-protein kinase receptor FLT3 inhibitor | |||
| 0.081 | 0.079 | 0.081 | Thioredoxin inhibitor | |||
| 0.099 | 0.097 | 0.099 | RET inhibitor | |||
| 0.021 | 0.02 | 0.021 | Isoleucine-tRNA ligase inhibitor | |||
| 0.018 | 0.016 | 0.018 | Inosine monophosphate dehydrogenase 1 inhibitor | |||
| 0.116 | 0.118 | 0.31 | Protein-tyrosine phosphatase inhibitor | 0.31 0.017 CID_162951 | CID_162951 | |
| 0.036 | 0.041 | 0.043 | Guanylate cyclase inhibitor | 0.043 0.029 CID_162951 | CID_162951 | |
| 0.089 | 0.095 | 0.132 | Nav1.4 sodium channel blocker | 0.132 0.043 CID_162951 | CID_162951 | |
| 0.044 | 0.08 | 0.164 | HIV-1 integrase (3'-Processing) inhibitor | 0.164 0.012 CID_162951 | CID_162951 | |
| 0.032 | 0.083 | 0.069 | H+/K+-transporting ATPase inhibitor | 0.069 0.018 CID_162951 | CID_162951 | |
| 0.158 | 0.21 | 0.217 | Cholesterol antagonist | 0.217 0.151 CID_162951 | CID_162951 | |
| 0.03 | 0.1 | 0.129 | HIV-1 integrase (Strand Transfer) inhibitor | 0.129 0.015 CID_162951 | CID_162951 | |
| 0.126 | 0.199 | 0.183 | Antioxidant | 0.183 0.129 CID_162951 | CID_162951 | |
| 0.086 | 0.175 | 0.194 | Cell wall synthesis inhibitor | 0.194 0.032 CID_162951 | CID_162951 | |
| 0.03 | 0.12 | 0.108 | Factor IXa inhibitor | 0.108 0.008 CID_162951 | CID_162951 | |
| 0.031 | 0.138 | 0.09 | Carbonic anhydrase VA inhibitor | 0.09 0.03 CID_162951 | CID_162951 | |
| 0.012 | 0.119 | 0.052 | Estrogen agonist | 0.052 0.034 CID_162951 | CID_162951 | |
| 0.052 | 0.166 | 0.084 | Breast cancer-resistant protein inhibitor | 0.084 0.074 CID_162951 | CID_162951 | |
| 0.074 | 0.197 | 0.372 | Angiogenesis stimulant | 0.372 0.027 CID_162951 | CID_162951 | |
| 0.025 | 0.15 | 0.124 | Carbonic anhydrase V inhibitor | 0.124 0.02 CID_162951 | CID_162951 | |
| 0.05 | 0.185 | 0.132 | Triose-phosphate isomerase inhibitor | 0.132 0.026 CID_162951 | CID_162951 | |
| 0.051 | 0.234 | 0.16 | Thrombolytic | 0.16 0.074 CID_162951 | CID_162951 | |
| 0.025 | 0.22 | 0.069 | Carbonic anhydrase XIII inhibitor | 0.069 0.059 CID_162951 | CID_162951 | |
| 0.03 | 0.227 | 0.119 | Protein-tyrosine phosphatase 1B inhibitor | 0.119 0.064 CID_162951 | CID_162951 | |
| 0.013 | 0.257 | 0.047 | Purinergic P2Y2 antagonist | 0.047 0.012 CID_162951 | CID_162951 | |
| 0.005 | 0.309 | 0.033 | 1,3-Beta-glucan synthase inhibitor | 0.033 0.009 CID_162951 | CID_162951 | |
| 0.011 | 0.336 | 0.177 | NMDA 2B receptor antagonist | 0.177 0.007 CID_162951 | CID_162951 | |
| 0.025 | 0.406 | 0.055 | Adenine nucleotide translocase inhibitor | 0.055 0.039 CID_162951 | CID_162951 | |
| 0.009 | 0.507 | 0.081 | CDC25A inhibitor | 0.081 0.043 CID_162951 | CID_162951 | |
| 0.006 | 0.513 | 0.097 | Selectin antagonist | 0.097 0.029 CID_162951 | CID_162951 | |
| 0.006 | 0.52 | 0.047 | NMDA 2D receptor antagonist | 0.047 0.008 CID_162951 | CID_162951 | |
| 0.01 | 0.561 | 0.671 | Cholecystokinin B agonist | 0.671 0.001 CID_162951 | CID_162951 | |
| 0.003 | 0.559 | 0.078 | Estrone sulfatase inhibitor | 0.078 0.005 CID_162951 | CID_162951 | |
| 0.014 | 0.617 | 0.189 | Dual specificity phosphatase 3 inhibitor | 0.189 0.067 CID_162951 | CID_162951 | |
| 0.017 | 0.628 | 0.178 | Dual specificity phosphatase inhibitor | 0.178 0.068 CID_162951 | CID_162951 | |
| 0.022 | 0.677 | 0.171 | Platelet adhesion inhibitor | 0.171 0.087 CID_162951 | CID_162951 | |
| 0.008 | 0.665 | 0.082 | Thrombin inhibitor | 0.082 0.04 CID_162951 | CID_162951 | |
| 0.01 | 0.697 | 0.387 | Anticoagulant | 0.387 0.017 CID_162951 | CID_162951 | |
| 0.01 | 0.735 | 0.181 | Multidrug resistance-associated protein 1 inhibitor | 0.181 0.015 CID_162951 | CID_162951 | |
| 0.003 | 0.734 | 0.647 | Cholecystokinin A agonist | 0.647 0.002 CID_162951 | CID_162951 | |
| 0.003 | 0.757 | 0.698 | Cholecystokinin agonist | 0.698 0.002 CID_162951 | CID_162951 | |
| 0.002 | 0.918 | 0.264 | Cholecystokinin A antagonist | 0.264 0.004 CID_162951 | CID_162951 | |
| 0.002 | 0.942 | 0.167 | Cholecystokinin B antagonist | 0.167 0.004 CID_162951 | CID_162951 | |
| 0.002 | 0.945 | 0.182 | Cholecystokinin antagonist | 0.182 0.005 CID_162951 | CID_162951 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |